Lee, Angela
Fine, Nowell M.
Bril, Vera
Delgado, Diego
Hahn, Christopher
Article History
Received: 21 January 2022
Accepted: 29 April 2022
First Online: 25 June 2022
Declarations
:
: As this paper was a case report, the requirement for ethics approval was waived by the University of Calgary Cojoint Health Ethics Research Board.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: CH, NF, and DD report honoraria for speaking engagements and/or advisory boards with Pfizer, Sobi Therapeutics (formerly Akcea), and Alnylam. DD reports a research grant from Pfizer. NF reports research grants from Pfizer, Sobi Therapeutics, and Alnylam. VB reports consulting fees from Alnylam. AL reports no relevant disclosures.